Structural Characterization of Degradation Products Generated From Cenobamate Under Forced Degradation Conditions Using LC–HRMS/MS and NMR
SEPARATION SCIENCE PLUS · 2026-10 · 9 (10)
DOI: 10.1002/sscp.70326 ↗Kurz gefasst
Fachartikel in der Zeitschrift SEPARATION SCIENCE PLUS, online erschienen am 08.10.2026. Verfasst von Pushpa Pilli und 6 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Cenobamate (CEN) is a recently approved antiepileptic agent indicated for adults with focal‐onset epilepsy. Evaluation of its degradation behavior is essential for understanding its intrinsic stability and ensuring product quality, therapeutic efficacy, risk assessment, and consistent pharmaceutical performance. In the current study, the degradation behavior of cenobamate was explored in different stress conditions recommended by the International Council for Harmonisation (ICH), including oxidative, acidic, photolytic, thermal, and basic conditions, with the objective of identifying and characterizing degradation products generated during forced degradation. Among the investigated stress conditions, appreciable degradation was observed exclusively under acidic hydrolysis, resulting in the formation of two major degradation products. Efficient separation of cenobamate along with degradation products was achieved using RP‐HPLC‐PDA. Chromatographic separation was achieved on an Agilent ZORBAX SB‐C18 column (250 × 4.6 mm, 5 µm); catalogue number 880975‐902) employing an isocratic mode containing a mobile phase with acetonitrile and an aqueous solution holding 0.1% formic acid. The optimized chromatographic conditions afforded satisfactory resolution between the parent drug and its degradation products. Elucidation of structures along with their fragments for degradation products was done through liquid chromatography–high‐resolution tandem mass spectrometry, enabling precise mass measurements. Among the two DPs formed, the major degradation product (DP‐1) was enriched and structurally elucidated using one‐ ( 1 H, 1 3 C, DEPT) and two‐dimensional NMR (COSY, HSQC, and HMBC), confirming its proposed chemical structure. A plausible degradation pathway was established from the combined interpretation of LC‐HRMS/MS fragmentation data and NMR findings. In addition, the toxicity of cenobamate drug along with its degradation products was predicted using the SARAH Nexus and DEREK Nexus platforms. Overall, the study provides comprehensive insight into the degradation behavior of cenobamate and supports degradation product characterization, impurity profiling, pharmaceutical quality evaluation, and future stability investigations during pharmaceutical development and regulatory assessment.
Zitieren
APA
Pilli, P., Barik, P., Kommalapati, H. S., Pimpre, K., Kumari, A., Sireesha, D. S., & Samanthula, G. (2026). Structural Characterization of Degradation Products Generated From Cenobamate Under Forced Degradation Conditions Using LC–HRMS/MS and NMR. SEPARATION SCIENCE PLUS, 9(10). https://doi.org/10.1002/sscp.70326
Vancouver
Pilli P, Barik P, Kommalapati HS, Pimpre K, Kumari A, Sireesha DS, et al. Structural Characterization of Degradation Products Generated From Cenobamate Under Forced Degradation Conditions Using LC–HRMS/MS and NMR. SEPARATION SCIENCE PLUS. 2026;9(10). doi:10.1002/sscp.70326
BibTeX
@article{Pilli2026,
author = {Pilli, Pushpa and Barik, Prateek and Kommalapati, Hema Sree and Pimpre, Kavita and Kumari, Anuradha and Sireesha, D. Satya and Samanthula, Gananadhamu},
title = {Structural Characterization of Degradation Products Generated From Cenobamate Under Forced Degradation Conditions Using LC–HRMS/MS and NMR},
journal = {SEPARATION SCIENCE PLUS},
year = {2026},
volume = {9},
number = {10},
doi = {10.1002/sscp.70326}
}
EUVIMED